Abstract. The current study aimed to identify gene signatures during rheumatoid arthritis (RA) and osteoarthritis (OA), and used these to elucidate the underlying modular mechanisms. Using the Gene Expression Omnibus database, the present study obtained the GSE7669 mRNA expression microarray data from RA and OA synovial fibroblasts (n=6 each). The differentially expressed genes (DEGs) in RA synovial samples compared with OA samples were identified using the Linear Models for Microarray Analysis package. The Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed using the Database for Annotation Visualization and Integrated Discovery. A protein-protein interaction network was constructed and the modules were further analyzed using the Molecular Complex Detection plugin of Cytoscape. A total of 181 DEGs were identified by comparing RA and OA synovial samples (96 up-and 85 downregulated genes). The significant DEGs in module 1, including collagen, type I, α 1 (COL1A1), COL3A1, COL4A1 and COL11A1, were predominantly enriched in the extracellular matrix (ECM)-receptor interaction and focal adhesion pathways. Additionally, significant DEGs in module 2, including radical S-adenosyl methionine domain containing 2 (RSAD2), 2'-5'-oligoadenylate synthetase 2 (OAS2), myxovirus (influenza virus) resistance 1 (MX1) and ISG15 ubiquitin-like modifier (ISG15), were predominantly associated with immune function pathways. In conclusion, the present study indicated that RSAD2, OAS2, MX1 and ISG15 may be notable gene signatures in RA development via regulation of the immune response. COL3A1, COL4A1, COL1A1 and COL11A1 may be important gene signatures in OA development via involvement in the pathways of ECM-receptor interactions and focal adhesions.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease which can lead to progressive disability, early mortality and other systemic complications (1) . RA is incurable, has high socioeconomic costs and severely reduces the quality of life of patients (2) . Osteoarthritis (OA) is the most common joint disease; it causes pain, disability and the loss of joint function (3) . OA is also a chronic and incurable illness that lacks effective treatment strategies (4) . Thus, advances in the understanding of the molecular mechanisms underlying these two diseases may lead to the development of novel therapeutic strategies.
RA is characterized by autoimmune and synovial inflammation, the destruction of multiple joints and the formation of pannus (5) . OA is characterized by an inflammatory response and progressive breakdown of the articular cartilage of the joint (6) . Genetic factors have been implicated in the development of these diseases (7, 8) . The human leukocyte antigen molecules and their relevant immunological pathways have been associated with RA pathogenesis (9) . Sun et al (10) demonstrated that paired immunoglobin-like type receptor α was associated with inflammatory cell infiltration and was elevated in the synovial tissue from mice with RA. In addition, a genome-wide association and functional study suggests that DOT1-like histone H3K79 methyltransferase is associated with cartilage thickness and hip OA (11) . Valdes et al (12) also confirmed that genetic variation in the SMAD family member 3 gene may result in the progression of hip and knee OA. Together, these findings indicate the importance of genetic mechanisms in the pathogenesis of RA and OA. Despite previous progress, the gene signatures associated with the pathogenesis of RA and OA remain unknown, and reliable predictive biomarkers for prognosis and treatment are lacking.
Microarray analyses have been increasingly used to identify disease-associated genes and pathways for elucidation of the molecular mechanisms of RA and OA (13, 14) . In a previous study, the GSE7669 microarray data was used to analyze differentially expressed genes (DEGs) between RA and OA using a gene co-expression network (15), or to screen candidate genes associated with RA by investigating core and periphery interaction structures (16) . By contrast, the current study used this microarray data and comprehensive bioinformatics methods to identify DEGs in synovial RA samples compared with OA samples. Additionally, the present study performed functional enrichment analysis for DEGs and functional module analysis of the protein-protein interaction (PPI) network. The current study aimed to identify important disease-associated genes and the molecular mechanisms involved in RA and OA.
Materials and methods
Affymetrix microarray data. The GSE7669 gene expression profile deposited by Pohlers et al (17) was downloaded from Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/), which was based on the platform of Affymetrix Human Genome U95 Version 2 Array (Affymetrix, Inc., Santa Clara, CA, USA). This dataset included the gene expression profiles from the synovial fibroblasts of 6 patients with RA and 6 patients with OA.
Data preprocessing and DEG screening. All the raw expression data was preprocessed using the Affymetrix package (18) in R (cran.at.r-project.org) and Bioconductor (www.bioconductor.org), and the normalization was performed using the robust multiarray average algorithm (19 the information of the STRING database, DEGs with the combined protein interaction score >0.4 were selected and used to construct a PPI network in the present study. Hub proteins (25) in the PPI network were identified based on connectivity degree analysis. The PPI network was visualized using Cytoscape software (www.cytoscape.org) (26) .
Functional module analysis of PPI network. The functional modules of the PPI network were subsequently identified using the Molecular Complex Detection (MCODE) (27) plugin of Cytoscape. The parameters were set as follows: Degree cut-off, 2; node score cut-off, 0.2; K-core, 2; and max depth, 100. Functional enrichment analyses for DEGs in functional modules with higher degree and node scores were subsequently performed using the DAVID tool. P<0.05 and gene count >2 were considered to indicate a statistically significant difference.
Results

DEG screening.
Comparing OA and RA samples, a total of 181 DEGs were obtained, in which 96 genes were upregulated in RA and downregulated in OA samples, and 85 genes were downregulated in RA and upregulated in OA samples.
Functional enrichment analyses. The GO BP terms and KEGG pathway analyses were conducted for functional annotation of the DEGs. The top 10 GO BP terms are presented in Table I . The results demonstrated that the upregulated genes were significantly enriched in functions associated with cell adhesion, biological adhesion and extracellular matrix (ECM) organization. Downregulated genes were predominantly associated with the regulation of cell death, and responses to hormone and endogenous stimuli. In addition, 3 and 2 KEGG pathways were significantly enriched by up-and downregulated DEGs, respectively (Table II) . The enriched KEGG pathways for the upregulated genes were ECM-receptor interactions, focal adhesions and the TGF-β signaling pathway, whereas the pathways enriched by the downregulated genes included the TGF-β signaling pathway and vascular smooth muscle contraction (Table II) .
PPI network analysis.
Based on the information of the STRING database, a total of 343 protein interactions with combined scores >0.4 were included in the PPI network (Fig. 1) . The top 20 hub proteins were identified according to connectivity degree (Table III) , including collagen type I α 1 (COL1A1), COL1A2, COL3A1, COL4A2, integrin α 1, COL4A1, biglycan and COL11A1. Notably, in addition to interferon-induced protein with tetratricopeptide repeats 3, these hub nodes were upregulated and the majority of them are collagen proteins.
Functional module analysis of PPI network. In order to improve analysis of the PPI network, 5 modules were detected using the MCODE plugin. Only 2 module scores were >10 and the scores of other modules were not >3.5. Module 1, with the highest node score (11.455), consisted of 12 nodes and 63 edges, in which upregulated genes, including COL3A1, COL4A1, COL1A1 and COL11A1 were included ( Fig. 2A) . Module 2 (node score=11) consisted of 11 nodes and 55 edges, in which the downregulated genes were included (Fig. 2B) . The downregulated genes in module 2 included radical S-adenosyl methionine domain containing 2 (RSAD2), 2'-5'-oligoadenylate synthetase 2 (OAS2), myxovirus (influenza virus) resistance 1 (MX1) and ISG15 ubiquitin-like modifier (ISG15).
In addition, functional enrichment analyses for DEGs in the functional modules were performed. Module 1 was predominantly associated with the regulation of cell proliferation, response to wounding and wound healing (Table IV) . Module 2 was predominantly associated with immune functions, including the response to viruses, defense response and immune response (Table IV) . The significantly enriched pathways of module 1 were ECM-receptor interaction and focal adhesion, whereas, no pathways were significant for module 2 (Table IV) . 
A B Discussion
There is a lack of effective treatments for RA and OA, and exploring the gene signatures associated with the diseases may elucidate the molecular pathogenesis and provide opportunities for biomarker development. The results of the present study demonstrated that the significant DEGs of module 1, including COL3A1, COL4A1, COL1A1 and COL11A1, were predominantly enriched in the ECM-receptor interaction and focal adhesion pathways. Additionally, the DEGs of module 2, including RSAD2, OAS2, MX1 and ISG15, were predominantly associated with immune responses. All these DEGs and pathways may be important mechanisms in the development of RA and OA. In a previous study, Olex et al (28) identified the ECM-receptor interaction pathway to be an important signaling and metabolic pathway during the progression of OA. Koelling et al (29) also demonstrated that several dysregulated genes in OA samples were associated with ECM-receptor interactions and focal adhesions. In the present study, DEGs, including COL3A1, COL4A1, COL1A1 and COL11A1, were predominantly enriched in the ECM-receptor interaction and focal adhesion pathways. It can, therefore, be speculated that the these pathways may contribute to OA progression. Additionally, COL3A1 is a gene important for cartilage function, and its expression was previously observed to be correlated with the radiographic severity of canine elbow OA (30). Cui et al (31) demonstrated that COL3A1 expression was enriched in the focal adhesion pathway, which may suggest a molecular mechanism of OA. Furthermore, COL4A1 was previously identified as an OA-associated gene involved in the development of the disease (32) . Gene expression analysis also indicated that COL1A1 was dysregulated in TGF-β-stimulated OA samples (33) . COL11A1 was demonstrated to be an OA susceptibility gene in human joint tissues and is important in the development of this degenerative musculoskeletal disease (34) . Additionally, a previous investigation demonstrated that multiple collagen genes (COL1A1, COL2A1, COL3A1 and COL4A1) were associated with the progression of OA (28) . Collagen derivatives are candidates for disease-modifying OA drugs and are marketed as having therapeutic effects on reducing the symptoms of OA (35) . Therefore, it is speculated that these collagens may be important gene signatures of OA and have implications in the progression of this disease through effects on ECM-receptor interactions and focal adhesions.
Furthermore, the innate immune response is understood to cause inflammation and joint destruction in RA, and a (38, 39) . OAS2 is involved in the IFN β signaling pathway, and investigation of core and periphery interaction structures previously identified it as a candidate gene associated with RA (16) . MX1 is also an IFN response gene and was previously demonstrated to be correlated with disease activity in fibroblast cells of RA synovial tissue (40) . ISG15 sensitizes the IFN-activated JAK-STAT pathway, which is established to be important in RA development (41) . Additionally, type I IFN has been demonstrated to enhance immune responses in vivo and acts as a signal linking innate and adaptive immunity (42) . Smith et al (43) demonstrated that, as type I IFN signatures, RSAD2, OAS2 and MX1 may be important for predicting treatment response in RA. Therefore, the DEGs identified in the present study may be crucial gene signatures for elucidating the molecular pathogenesis of RA.
In conclusion, the results of the current study indicate that RSAD2, OAS2, MX1 and ISG15 may be RA gene signatures, and may be associated with RA development via effects on immune responses. COL3A1, COL4A1, COL1A1 and COL11A1 may be important gene signatures contributing to OA development via involvement in ECM-receptor interactions and focal adhesion. The present findings aid the clarification of the molecular mechanisms of RA and OA. However, the sample size used in the current study was small. Additional experiments, including reverse transcription-quantitative polymerase chain reaction and western blot analysis, were not performed to confirm the mRNA and protein expression levels of these gene signatures. Thus, further studies are required to investigate the potential clinical applications of these gene signatures.
